The Management of Gestational Trophoblastic Tumors with Etoposide, Methotrexate, and Actinomycin D

By Soto-Wright V.   Goldstein D.P.   Bernstein M.R.   Berkowitz R.S.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 156-159

Elsevier

Access to resources Recommend Favorite

Combination Chemotherapy with Methotrexate, Etoposide, and Actinomycin D for High-Risk Gestational Trophoblastic Tumors

By Matsui H.   Suzuka K.   Iitsuka Y.   Seki K.   Sekiya S.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 28-31

Elsevier

Access to resources Recommend Favorite

Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy*

By Escobar P.F.   Lurain J.R.   Singh D.K.   Bozorgi K.   Fishman D.A.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 552-557

Elsevier

Access to resources Recommend Favorite

Guidelines for the Stratification of Patients Recruited to Trials of Therapy for Low-Risk Gestational Trophoblastic Tumor

By Nevin J.   Silcocks P.   Hancock B.   Coleman R.   Nakielny R.   Lorigan P.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 92-96

Elsevier

Access to resources Recommend Favorite

Risk Factors for the Prediction of Treatment Failure in Gestational Trophoblastic Tumors Treated with EMA/CO Regimen

By Kim S.J.   Bae S.N.   Kim J.H.   Kim C.J.   Jung J.K.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 247-253

Elsevier

Access to resources Recommend Favorite